The financial markets have a curious relationship with the physical wellbeing of world leaders. We treat it as a risk factor, a variable in the great algorithm of capital flows. So when President Donald Trump’s medical team announced a ‘routine check-up’ this week, the City’s collective eyebrow raised.
The timing, the lack of transparency, the carefully stage-managed photo of a leader in robust health – it all felt rather familiar. But then came the contrast. Across the Atlantic, King Charles III released his full medical records, a move so transparent it almost seemed a rebuke.
Let’s cut through the spin. First, Trump’s check-up. The White House doctor, Dr Sean Barbabella, issued a statement declaring the President in ‘excellent health’, with a cognitive score that would make a man half his age envious.
The problem is that this is a man who has spent years fighting the release of his tax returns, his business dealings and, yes, his medical history. The last time he underwent a ‘surprise’ health check, in 2020, it was followed by a helicopter ride to Walter Reed military hospital and a bout of Covid that nearly killed him. The market memory is long.
For investors, the concern is not whether Trump can run a marathon but whether he can govern a country. A lack of transparency breeds uncertainty, and uncertainty is the enemy of efficient pricing. The dollar barely reacted, but gilt yields in London ticked up a basis point on the news – a signal that the market is pricing in a higher risk premium for US political stability.
Now consider the King’s move. The Palace released a detailed report, including the monarch’s full pathology results, his orthopaedic history and even a note on his sleep patterns. This is a man who runs a family firm that has seen its fair share of scandals, from Diana to Epstein.
The message is clear: transparency is the best antidote to speculation. The Crown is a long bond, and long bonds demand trust. By baring all, His Majesty has effectively reduced the ‘king risk’ premium.
The cost of insuring UK sovereign debt via credit default swaps actually ticked down after the release. Coincidence? Perhaps.
But in the world of high finance, perception is reality. The juxtaposition is instructive. One leader treats his health as a state secret, the other as a public good.
The market will always reward the latter. For investors, the lesson is simple: watch the medical records as closely as the balance sheets. The body politic has a tell, and it’s usually a blood pressure reading.
